Campaigners are urging NHS England to make the breast cancer drug Enhertu available for patients who need it. Multiple reports say women are dying of breast cancer while the life-extending treatment remains blocked in England, and they point to calls for the drug to be funded through the NHS. The campaign’s central message is that patients should not face delays or lack of access to a therapy that can extend life. The coverage focuses on the ongoing access decision and the impact on people with advanced disease, framing the issue as one of whether the drug will receive approval or funding for routine use. The reports also highlight that the request is directed at NHS decision-makers, with campaigners pressing for timely action. While the specific reasons for the current funding or availability status are not described in the provided extracts, all accounts align on the existence of a campaign, the continued lack of NHS availability in England, and the drug identified as Enhertu.